Vuzix® Corporation Announces Pixee Medical Completes its First Total Knee Replacement Surgery Guided Solely by the Vuzix M400 Smart Glasses

Vuzix M400 Smart Glasses: Vuzix® Corporation a supplier of Smart Glasses and Augmented Reality (AR) technology and products, announce that Pixee Medical, a France-based medical company, in collaboration with Dr. Jérôme Villeminot and his team from Clinique St Odile in Haguenau (France), has successfully validated a new milestone by using Knee+, the first total knee replacement AR navigation system, solely guided by the Vuzix M400 AR Smart Glasses.

Vuzix M400 Smart Glasses running the Knee+ solution provided real-time navigation throughout the surgery, displaying essential augmented reality information in the surgeon’s field of view.

The most recent surgery also marked the first ambulatory surgery using Pixee’s MIS solution.  During the last 2 months, Pixee successfully achieved the first round of the Knee+ clinical validation program. This major milestone starts the second round of validation, opening the way to the first limited commercialization of their innovative solution in November 2020.  Pixee has a growing list of surgeons and orthopedic manufacturers worldwide interested in trying this innovation using the Vuzix M400 Smart Glasses. The combination is compact, easy to use, wireless, and does not require disposables.

“The team at Pixee Medical created an innovative path to bring the Vuzix M400 Smart Glasses into the operating room to perform knee replacement surgeries and continues to make progress in the operating theater for a variety of uses.  We look forward to supporting them in their worldwide distribution of this innovative AR solution,” said Paul Travers, President, and Chief Executive Officer at Vuzix.

Hot this week

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution